GlassScriptPhysician profile
Igor Kofman
NPI 1780845180
$5,340.14
in general payments reported to CMS, 2019-2025
12 companies · $4,960 in 2025
The $4,960 reported for 2025 was more than what 90% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $18.10 · 2022: $20.00 · 2023: $245 · 2024: $96.31 · 2025: $4,960.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Travel and Lodging: $880 · Food and Beverage: $422.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Travel and Lodging | $879.88 |
| Food and Beverage | $422.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,914.28 | 2025 | |
| Medtronic, INC. | $107.74 | 2023-2024 | Signia |
| Tela Bio, INC. | $83.44 | 2022-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Davol INC. | $37.75 | 2023 | Phasix Mesh |
| Ethicon US, LLC | $34.66 | 2023 | Echelon Flex, Enseal |
| Cumberland Pharmaceuticals, INC. | $31.46 | 2023-2024 | Caldolor |
| Kerecis Limited | $31.22 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Sanara Medtech INC. | $29.64 | 2024 | Celleraterx |
| W. L. Gore & Associates, INC. | $22.55 | 2023 | Gore Synecor Biomaterial |
| Avanos Medical | $18.10 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $14.75 | 2025 | Exparel |
| Kowa Pharmaceuticals America, INC. | $14.55 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Igor Kofman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.